Financial Performance

With its new $100M Fund IV, Corazon Capital is doubling down on its operator-led model to back early-stage AI startups focused on amplifying human potential.

Longhorn Diagnostics unveils LHNVD-501, a novel antibody targeting a universal bacterial component, offering a new front against AMR and chronic inflammation.

Construction starts on Canada's next-gen polar icebreaker, a project to secure Arctic sovereignty, create jobs, and test a new international shipbuilding model.

A new intelligence firm is ditching child surveillance to fight online harm by exposing platform design flaws and arming lawsuits against Big Tech.

Private equity firm Mountaingate Capital acquires UpSwell Marketing, signaling a major trend: investing in tech that proves marketing’s bottom-line value.

Marucci and Victus partner with Axe Bat, bringing ergonomic handle tech to the masses. See how analytics is changing the game from the grip up.

Following its major merger with SubjectWell, Clariness unveils a new CEO and executive team, signaling a push to dominate the patient recruitment market.

A new report reveals the crushing weight of debt on American life, fueling widespread stress, regret, and impacting the financial future for millions.

SmartBear launches a wave of AI enhancements, positioning human-AI collaboration as the key to ensuring software integrity in an AI-driven world.

Your wellness tea may be missing a key ingredient: safety certification. Experts warn of risks as unverified functional beverages flood the market.

As teens grow up on algorithms, one expert says schools are failing them. She proposes a radical shift: using tech as a tool, not a distraction.

As geopolitical conflict sends gas prices soaring, a new free tool from nonprofit Coltura shows drivers how much they could save by going electric.

EV charging firm Hypercharge signals a new era of aggressive expansion, hiring a corporate development expert as its co-founder steps down from the board.

LabConnect launches a new smartphone app to replace outdated digital pens, promising real-time sample tracking and fewer errors in clinical research.

The pharma giant expands its collaboration with OpenProtein.AI, integrating advanced AI to accelerate the creation of new drugs for cancer and autoimmune diseases.

A new Phase 2 trial for an oral pill offers hope for patients with M. abscessus lung disease, a severe infection with no approved treatments.

Successful trials of high-yield castor seeds in Brazil show economic viability, positioning the non-edible crop as a major new feedstock for biofuels.

As a wall of corporate debt looms over Europe, the investment firm hires a top specialist to lead its expansion and capitalize on market dislocations.

The architect of the Raptors' NBA title, Masai Ujiri, joins the Toronto Tempo ownership, launching a global initiative to empower women in basketball.

For the first time, the world's most prestigious jazz contest heads abroad, partnering with Fondation Louis Vuitton to find the next great jazz vocalist.